International Early Lung Cancer Action Program (I-ELCAP)
Hospitals And Health Care
New York, Ny, United States
126 employees
- Employees
- 126
International Early Lung Cancer Action Program (I-ELCAP) Overview
- Headquarters
- New York, Ny, United States
- Website
- www.ielcap.org
- Industry
- Hospitals And Health Care
- Employees
- 126
- NAICS
-
Health Care and Social AssistanceSocial Assistance
About International Early Lung Cancer Action Program (I-ELCAP)
The International Early Lung Cancer Action Program (I-ELCAP) is an ongoing screening program that began accruing participants in 1994. It initially had two participating institutions, NYU and Cornell and now includes over 80 sites worldwide. The Principal Investigator for this program is Claudia Henschke PhD, MD, who is currently at Mount Sinai Hospital, which is the coordinating center for the program. I-ELCAP is the largest multi-center screening program in the world having already accrued over 80,000 participants and new sites continue to enroll. The program strives to be at the forefront of both innovation and clinical care, which has helped to set the standard in screening that has been adopted globally.
Compare Similar Companies to International Early Lung Cancer Action Program (I-ELCAP)
American Cancer Society
Non-Profit Organizations
IARC - International Agency for Research on Cancer / World Health Organization
Research Services
Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy
Education
HeartLung.AI
Wellness And Fitness Services
Lung Cancer Policy Network
Public Health
Asia Pacific Coalition against Lung Cancer
Health And Human Services
Accumetra, LLC
Medical Equipment Manufacturing
SHAPE Society (Society for Heart Attack Prevention and Eradication)
Non-Profit Organizations
Build a Print Shop
Embedded Software Products
MRinRT 2025
Research Services